NCT03783325

Brief Summary

This research study is designed to better understand the role of genetics, sun-exposure and phenotypic factors in melanoma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 17, 2017

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

December 13, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 21, 2018

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2022

Completed
Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

5.3 years

First QC Date

December 13, 2018

Last Update Submit

October 19, 2023

Conditions

Keywords

Sun ExposureUV DosimetryBiomarkersBehaviorsGenetics

Outcome Measures

Primary Outcomes (11)

  • Sun Exposure Behaviors

    A short questionnaire is administered during the clinic visit to assess sun exposure behaviors of melanoma patients. The data gathered from this questionnaire will help identify possible trends in sun exposure behaviors and provide a baseline dataset for future research,

    Start of study, initial interaction with participants.

  • UV Exposure Assessment

    Identify the difference between self-reported sun exposure behavior and actual UV exposure by having patients wear individual dosimeters

    Start of study to end of study, up to 6 weeks

  • Visual Appearance Relationships: Melanoma, Questionnaire

    Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in melanoma patients using a sun exposure questionnaire

    Start of study to end of study, up to 3 years

  • Visual Appearance Relationships: Non-Melanoma , Questionnaire

    Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in non-melanoma patients using a sun exposure questionnaire

    Start of study to end of study, up to 3 years

  • Visual Appearance Relationships: Melanoma, Photography

    Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in melanoma patients using a UV photography

    Start of study to end of study, up to 3 years

  • Visual Appearance Relationships: Non-Melanoma, Photography

    Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in non-melanoma patients using a UV photography

    Start of study to end of study, up to 3 years

  • Visual Appearance Relationships: Melanoma, Casting

    Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in melanoma patients using a silicone casts

    Start of study to end of study, up to 3 years

  • Visual Appearance Relationships: Non-Melanoma, Casting

    Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in non-melanoma patients using a silicone casts

    Start of study to end of study, up to 3 years

  • Visual Appearance Relationships: Melanoma, SCINEXA

    Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in melanoma patients using a SCINEXA exam.

    Start of study to end of study, up to 3 years

  • Visual Appearance Relationships: Non-Melanoma, SCINEXA

    Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in non-melanoma patients using a SCINEXA exam.

    Start of study to end of study, up to 3 years

  • Genetics Correlations

    Determine whether UV exposure and camera scores correlates with UV signature (somatic) mutations and other tumor-related mutations in clinically benign nevi and primary melanomas using saliva samples, benign nevi, and primary melanomas. Next Generation Sequencing (NGS) will be used to obtain the genetic information from all samples.

    Start of study to end of study, up to 3 years

Secondary Outcomes (10)

  • Self Reporting Behaviors

    Start of study to end of study, up to 3 years

  • Behavioral Intervention and Immediate Follow Up

    After wearing dosimetry for 3 weeks

  • Benign Nevi, DNA

    Start of study to end of study, up to 3 years

  • Benign Nevi, Mutations

    Start of study to end of study, up to 3 years

  • Benign Nevi, Exposure

    Start of study to end of study, up to 3 years

  • +5 more secondary outcomes

Study Arms (3)

UV Counseling

OTHER

Evaluate the effectiveness of dosimetry feedback on sun exposure behaviors, attitudes, and awareness in patients diagnosed with melanoma.

Behavioral: UV Counseling

Visual Analysis - UV Photo

EXPERIMENTAL

Assess the relationships between UV camera score, silicone mold of a skin patch, phenotypic evaluation and sun-exposure behaviors. Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.

Other: UV Photo

Biological Sample

EXPERIMENTAL

Determine the relationship between measures of sun exposure and genomic characteristics of tumors in melanoma patients. Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.

Other: Biological Sample

Interventions

UV CounselingBEHAVIORAL

This is a sub-study that involves a behavioral intervention. Participants will wear a UV dosimetry for 3 weeks, return the device and receive feedback. After the feedback, they will re-wear the device for an additional 3 weeks.

UV Counseling

Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.

Visual Analysis - UV Photo

Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.

Biological Sample

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> or = 18 years of age
  • Patient at the University of Colorado Anschutz Medical Campus Cutaneous Oncology Clinic or Dermatology Clinic OR attend the fundraising event of the Colorado Melanoma Foundation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado

Aurora, Colorado, 80045, United States

Location

MeSH Terms

Conditions

Nevi and MelanomasBehavior

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasms

Study Officials

  • Neil Box, PhD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Patients will have the opportunity to participate in a questionnaire and then they are given the option to participate in substudy A (wear a UV dosimeter, complete questionnaires, and receive feedback based on the UV dosimeter results), subtstudy B (wear a skin patch, participate in a UV photo analysis, answer questionnaires), and/or substudy C (give biological samples via nevi).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2018

First Posted

December 21, 2018

Study Start

February 17, 2017

Primary Completion

June 17, 2022

Study Completion

June 17, 2022

Last Updated

October 23, 2023

Record last verified: 2023-10

Locations